Tirzepatide: Known as Mounjaro (for diabetes) and Zepbound (for weight loss), tirzepatide targets both GLP-1 and GIP receptors, offering enhanced metabolic benefits
The findings here highlight that to maintain weight loss, people should continue on tirzepatide long-term, says Fatima Cody Stanford, MD, MPH, an associate professor of medicine at Harvard Medical School and obesity medicine specialist at Massachusetts General Hospital, both in Boston
By the third and fourth weeks, appetite control becomes stronger
Additionally, if you have questions or need personalized advice, telehealth services like Doctronic.ai offer convenient access to medical professionals who understand the latest in modern medicine and can provide guidance tailored to your needs
Food & Drug Administration, Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity (2024)